PROVO, Utah - Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness company, reported on Monday that its preliminary revenue for the fourth quarter of 2024 is at the high end of its guidance range. This news comes as the company's stock trades near its 52-week low of $6.22, down significantly from its high of $19.30. According to InvestingPro analysis, Nu Skin appears undervalued based on its Fair Value metrics, despite facing recent market challenges. The announcement comes ahead of the company's participation in the ICR Conference scheduled for Tuesday, where President and CEO Ryan Napierski and CFO James Thomas will engage in a fireside chat.
The discussion at the ICR Conference will cover Nu Skin's business strategies, performance, and the recent acquisition of Mavely for $250 million. The presentation is set to be webcast live at 3 p.m. ET and will be accessible through the investor relations page on the Nu Skin website, with an archive of the webcast available until January 28.
Further financial details for the fourth quarter and the full year of 2024 will be disclosed after the market closes on February 13, followed by a conference call with the investment community later that day. The call will be webcast on the company's investor relations page, with a replay available through February 27.
Nu Skin operates in nearly 50 markets worldwide and is known for its personal care, nutrition, and anti-aging products, including the award-winning ageLOC line of beauty device systems. The company maintains impressive gross profit margins of 74.4% and has maintained dividend payments for 24 consecutive years, demonstrating operational efficiency despite market challenges. InvestingPro subscribers have access to 12 additional key insights and a comprehensive Pro Research Report that provides deep-dive analysis of Nu Skin's financial health and market position. The company is part of the Nu Skin Enterprises family, which includes Rhyz Inc., a conglomerate formed in 2018 to foster innovation in beauty, wellness, and lifestyle sectors.
This press release contains forward-looking statements, which are based on current management expectations and are subject to risks and uncertainties that could cause actual results to differ materially. While analysts expect net income growth this year, these statements include projections about the company's fourth-quarter revenue and are subject to change based on the completion of closing and audit procedures. Nu Skin has cautioned that these preliminary results are not a guarantee of future performance and that they may be adjusted following the finalization of financial statements.
The information provided in this article is based on a press release statement from Nu Skin Enterprises Inc.
In other recent news, Nu Skin Enterprises Inc. has made significant strides in its business operations. The company, through its subsidiary Rhyz Inc., has sold its Mavely affiliate marketing platform to Later for an estimated sum of $250 million. The deal, which includes cash and a minority equity stake in the merged Later/Mavely entity, is a strategic move expected to enhance Nu Skin's capabilities in its beauty, wellness, and lifestyle ecosystem.
Nu Skin's sale of Mavely represents a substantial return on investment, with the proceeds intended for debt reduction and funding further innovation. The company also plans to leverage its stronger balance sheet to repurchase stock, aiming to deliver shareholder value. This is a recent development that underscores the company's commitment to innovation and growth within its core businesses.
In addition to this significant transaction, Nu Skin Enterprises has been the subject of recent analyst attention. DA Davidson has revised its price target for the company from $11 to $7, maintaining a neutral rating. This adjustment follows the company's report of weaker-than-expected performance for Q3 2024 and a downward revision in its full-year guidance. Despite these challenges, DA Davidson analysts anticipate a potential deceleration in the revenue decline for 2025, buoyed by expected growth in Nu Skin's manufacturing business. These are some of the recent developments surrounding Nu Skin Enterprises.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.